Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

China · Delayed Price · Currency is CNY

17.52

-0.74 (-4.05%)

Aug 14, 2026, 3:00 PM CST

-8.18% (1Y)

Market Cap	15.30B -9.1%
Revenue (ttm)	5.21B -1.0%
Net Income	591.64M -9.9%
EPS	0.67 -9.5%
Shares Out	873.09M
PE Ratio	26.21
Forward PE	17.88
Dividend	0.20 (1.14%)
Ex-Dividend Date	Jun 11, 2026

Volume	60,852,749
Open	17.90
Previous Close	18.26
Day's Range	17.33 - 18.07
52-Week Range	12.05 - 22.25
Beta	0.02
Analysts	Buy
Price Target	19.75 (+12.73%)
Earnings Date	Aug 4, 2026

About SHA:603456

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecules, drug products, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1973

Employees 4,791

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603456

Full Company Profile

Financial Performance

In 2025, SHA:603456's revenue was 5.51 billion, an increase of 6.74% compared to the previous year's 5.16 billion. Earnings were 730.07 million, an increase of 20.46%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 603456 stock is "Buy." The 12-month stock price target is ¥19.75, which is an increase of 12.73% from the latest price.

Price Target

¥19.75

(12.73% upside)

Analyst Consensus: Buy

Stock Forecasts